Previous 10 | Next 10 |
BrainsWay Ltd. (BWAY) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ET Company Participants Bob Yedid – LifeSci Advisors Christopher von Jako – President and Chief Executive Officer Scott Areglado – Chief Financial Officer Co...
Brainsway press release ( NASDAQ: BWAY ): Q2 GAAP EPS of -$0.07 in-line. Revenue of $8.01M (+14.4% Y/Y) misses by $0.41M . For further details see: Brainsway GAAP EPS of -$0.07 in-line, revenue of $8.01M misses by $0.41M
Revenue Growth of 14% Year-over-Year in Q2 2022 Conference call to be held today, August 10, 2022, at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, Aug. 10, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company...
BURLINGTON, Mass. and JERUSALEM, July 27, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it wi...
The company boasts state-of-the-art technology with multi-usable helmets for different indications and more indications likely to be approved. International sales are another growth opportunity where the company has hardly scratched the surface. The shares are modestly valued, giv...
BrainsWay (NASDAQ:BWAY) has announced that, for the first time, the Israeli Ministry of Health has approved coverage applicable to its Deep TMS™ system for the treatment of depression. The inclusion of the treatment within Israel’s health basket of essential medical service...
BURLINGTON, Mass. and JERUSALEM, June 28, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY), (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, announced today that, for the first time, the I...
BURLINGTON, Mass. and JERUSALEM, June 22, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Chris...
BURLINGTON, Mass. and JERUSALEM, June 21, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Highm...
The following slide deck was published by BrainsWay Ltd. in conjunction with this event. For further details see: Brainsway (BWAY) Investor presentations - Slideshow
News, Short Squeeze, Breakout and More Instantly...
2024-07-16 23:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BURLINGTON, Mass. and JERUSALEM, June 17, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced its broad market...